Anticoagulation management in clinical practice: Preventing stroke in patients with atrial fibrillation

作者：Hickey Kathleen^*

来源：Heart & Lung, 2012, 41(2): 146-156.

DOI：10.1016/j.hrtlng.2011.07.008

• Atrial fibrillation
• Stroke
• Anticoagulation
• Cardioversion
• Risk stratification

Atrial fibrillation (AF) is a major and widely recognized risk factor for cardioembolic stroke. Prophylactic therapy for the prevention of stroke in patients with AF is often achieved through oral anticoagulation, specifically, with warfarin, which has been used for this purpose for more than SO years. Although warfarin therapy is effective when implemented appropriately, it is often underutilized and requires consistent monitoring to ensure both safety in avoiding bleeding and efficacy in preventing strokes. Because the burden of AF-related stroke continues to rise, healthcare professionals need to understand the strengths and limitations of current and emerging treatment options. This review outlines current practices for managing the risk of stroke with anticoagulation in patients with AF, and discusses how new oral anticoagulants may affect clinical practice.
Cite this article: Hickey, K. (2012, MARCH/APRIL). Anticoagulation management in clinical practice: Preventing stroke in patients with atrial fibrillation. Heart & Lung, 41(2), 146-156. doi:10.1016/j.hrtlng.2011.07.008.

• 出版日期2012-4